a7056324c0fa8411ade1951523554dcd  pmc_31943195.pdf
01c1c1ecf63e6ad231e3f1060e7c9d04abcd8d48  pmc_31943195.pdf
09e49ca9b702a1d6953fcc734015292b64f35288fdc6e82878298e35546019f5  pmc_31943195.pdf

Title:           Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan
Creator:         Adobe InDesign CC 2015 (Windows)
Producer:        Adobe PDF Library 15.0
CreationDate:    Sat Feb 22 10:13:28 2020 CET
ModDate:         Sat Feb 22 10:13:29 2020 CET
Custom Metadata: yes
Metadata Stream: yes
Tagged:          no
UserProperties:  no
Suspects:        no
Form:            none
JavaScript:      no
Pages:           13
Encrypted:       no
Page size:       595.276 x 782.362 pts
Page rot:        0
File size:       278909 bytes
Optimized:       yes
PDF version:     1.6


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
ERIOTF+TimesNewRomanMTStd            Type 1C           Custom           yes yes yes     56  0
OWERDL+TimesNewRomanMTStd-Bold       Type 1C           Custom           yes yes yes     57  0
KYETZT+TimesNewRomanMTStd-BoldIt     Type 1C           WinAnsi          yes yes yes     48  0
DQNDFH+TimesNewRomanMTStd-Italic     Type 1C           WinAnsi          yes yes yes     64  0
DQNDFH+TimesNewRomanMTStd-Italic     Type 1C           WinAnsi          yes yes yes     30  0


Jhove (Rel. 1.28.0, 2023-05-18)
 Date: 2024-10-02 04:16:10 CEST
 RepresentationInformation: pmc_31943195.pdf
  ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16)
  LastModified: 2023-03-31 11:43:51 CEST
  Size: 278909
  Format: PDF
  Version: 1.6
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 70
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    ViewerPreferences: 
     HideToolbar: false
     HideMenubar: false
     HideWindowUI: false
     FitWindow: false
     CenterWindow: false
     DisplayDocTitle: false
     NonFullScreenPageMode: UseNone
     Direction: L2R
     ViewArea: CropBox
     ViewClip: CropBox
     PrintArea: CropBox
     PageClip: CropBox
    PageLayout: SinglePage
    PageMode: UseThumbs
    Language: en-US
   Info: 
    Title: Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan
    Creator: Adobe InDesign CC 2015 (Windows)
    Producer: Adobe PDF Library 15.0
    CreationDate: Sat Feb 22 10:43:28 CET 2020
    ModDate: Sat Feb 22 10:43:29 CET 2020
   ID: 0x6cad533af917e54bacb357171e3b477b, 0x8bf531f4c985dfc4231802547c8fd5db
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1312
      ImageHeight: 1879
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
     Intent: RelativeColorimetric
     Name: X
   Fonts: 
    Type1: 
     Font: 
      BaseFont: KYETZT+TimesNewRomanMTStd-BoldIt
      FontSubset: true
      FirstChar: 83
      LastChar: 119
      FontDescriptor: 
       FontName: KYETZT+TimesNewRomanMTStd-BoldIt
       Flags: Serif, Nonsymbolic, Italic
       FontBBox: -266, -259, 1076, 942
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: DQNDFH+TimesNewRomanMTStd-Italic
      FontSubset: true
      FirstChar: 32
      LastChar: 151
      FontDescriptor: 
       FontName: DQNDFH+TimesNewRomanMTStd-Italic
       Flags: Serif, Nonsymbolic, Italic
       FontBBox: -271, -246, 1100, 904
       FontFile3: true
      Encoding: WinAnsiEncoding
      ToUnicode: true
     Font: 
      BaseFont: ERIOTF+TimesNewRomanMTStd
      FontSubset: true
      FirstChar: 30
      LastChar: 233
      FontDescriptor: 
       FontName: ERIOTF+TimesNewRomanMTStd
       Flags: Serif, Nonsymbolic
       FontBBox: -94, -241, 1006, 916
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: OWERDL+TimesNewRomanMTStd-Bold
      FontSubset: true
      FirstChar: 30
      LastChar: 242
      FontDescriptor: 
       FontName: OWERDL+TimesNewRomanMTStd-Bold
       Flags: Serif, Nonsymbolic
       FontBBox: -191, -241, 1065, 957
       FontFile3: true
      EncodingDictionary: 
       BaseEncoding: WinAnsiEncoding
       Differences: true
      ToUnicode: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 4.2.1-c316 54.253921, 2020/02/27-15:11:36">
<rdf:RDF xmlns:rdf= "http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<rdf:Description rdf:about=""
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xmp="http://ns.adobe.com/xap/1.0/"
	xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
	xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/"
	xmlns:jav="http://www.niso.org/schemas/jav/1.0/"
	xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/"
	xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/">
<xmp:CreateDate>2020-02-27T15:11:36+05:30</xmp:CreateDate>
<xmp:ModifyDate>2020-02-27T15:11:36+05:30</xmp:ModifyDate>
<xmp:MetadataDate>2020-02-27T15:11:36+05:30</xmp:MetadataDate>
<pdfx:Producer>Acrobat Distiller 10.1.7 (Windows)</pdfx:Producer>
<pdfx:WPS-ARTICLEDOI>10.1111/head.13731</pdfx:WPS-ARTICLEDOI>
<pdfx:WPS-JOURNALDOI>10.1111/(ISSN)1526-4610</pdfx:WPS-JOURNALDOI>
<pdfx:WPS-PROCLEVEL>3</pdfx:WPS-PROCLEVEL>
<dc:format>application/pdf</dc:format>
<dc:title>
<rdf:Alt>
	<rdf:li xml:lang="x-default">Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan</rdf:li> 
</rdf:Alt> 
</dc:title>
<xmpMM:DocumentID>uuid:47268157-6030-4c2e-8d7b-30169982e7b5</xmpMM:DocumentID>
<xmpMM:InstanceID>uuid:b75f6f05-bca4-493d-8274-74916cdf0157</xmpMM:InstanceID>
</rdf:Description>
</rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 576
     Sequence: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 240, 561, 240, 549
      Annotation: 
       Subtype: Link
       Rect: 421, 154, 521, 144
      Annotation: 
       Subtype: Link
       Rect: 268, 110, 478, 100
    Page: 
     Label: 577
     Sequence: 2
    Page: 
     Label: 578
     Sequence: 3
    Page: 
     Label: 579
     Sequence: 4
    Page: 
     Label: 580
     Sequence: 5
    Page: 
     Label: 581
     Sequence: 6
    Page: 
     Label: 582
     Sequence: 7
    Page: 
     Label: 583
     Sequence: 8
    Page: 
     Label: 584
     Sequence: 9
    Page: 
     Label: 585
     Sequence: 10
    Page: 
     Label: 586
     Sequence: 11
    Page: 
     Label: 587
     Sequence: 12
    Page: 
     Label: 588
     Sequence: 13
  Checksum: 10a07ef8
   Type: CRC32
  Checksum: a7056324c0fa8411ade1951523554dcd
   Type: MD5
  Checksum: 01c1c1ecf63e6ad231e3f1060e7c9d04abcd8d48
   Type: SHA-1
  Checksum: 09e49ca9b702a1d6953fcc734015292b64f35288fdc6e82878298e35546019f5
   Type: SHA-256